Loading…
Based on limited metadata, Apollo Care received an FDA Warning Letter on March 20, 2019, regarding drug products, indicating the company failed to meet federal regulatory requirements. Without access to the full letter text or specific subject line, the exact nature of the violations cannot be determined; however, common drug manufacturing or marketing violations may have been cited. The warning was issued under FDA's drug regulatory authority, which oversees manufacturing practices, product labeling, and safety compliance.